The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant

References

• Yang W, Wang Y, Li X, Yu P. Purification and structural characterization of Chinese yam polysaccharide and its activities. Carbohydr Polym. 2015;117:1021–1027. doi:10.1016/j.carbpol.2014.09.08225498730
   PubMed Web of Science ®Google Scholar
• Choi EM, Koo SJ, Hwang JK. Immune cell stimulating activity of mucopolysaccharide isolated from yam (Dioscorea batatas). J Ethnopharmacol. 2004;91(1):1–6. doi:10.1016/j.jep.2003.11.00615036459
   PubMed Web of Science ®Google Scholar
• Kong XF, Zhang YZ, Yin YL, et al. Chinese yam polysaccharide enhances growth performance and cellular immune response in weanling rats. J Sci Food Agric. 2009;89(12):2039–2044. doi:10.1002/jsfa.3688
   Web of Science ®Google Scholar
• Xue HY, Li JR, Liu YG, et al. Optimization of the ultrafiltration-assisted extraction of Chinese yam polysaccharide using response surface methodology and its biological activity. Int J Biol Macromol. 2019;121:1186–1193. doi:10.1016/j.ijbiomac.2018.10.12630342144
   PubMed Web of Science ®Google Scholar
• Zhi F, Yang TL, Wang Q, et al. Isolation, structure and activity of a novel water-soluble polysaccharide from Dioscorea opposita Thunb. Int J Biol Macromol. 2019;133:1201–1209. doi:10.1016/j.ijbiomac.2019.04.08730986466
   PubMed Web of Science ®Google Scholar
• Shi Y, Lian YU, Zhai M, et al. Effect of Nano Chinese Yam Polysaccharide on 4 kinds of tumor cells. Chinese j Modern Applied Pharm. 2016.
   Google Scholar
• Zhao GH, Zhi-Xiao LI, Chen ZDJAPS. Structural analysis and antitumor activity of RDPS-I polysaccharide from Chinese yam. Acta Pharmaceutica Sinica. 2003;38(1):37–41. doi:10.1023/A:1022865704606
   Google Scholar
• Li M, Chen L-X, Chen S-R, et al. Non-starch polysaccharide from Chinese yam activated RAW 264.7 macrophages through the Toll-like receptor 4 (TLR4)-NF-κB signaling pathway. J Funct Foods. 2017;37:491–500. doi:10.1016/j.jff.2017.08.025
   Web of Science ®Google Scholar
• Luo L, Qin T, Huang Y, et al. Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo. Drug Deliv. 2017;24(1):1099–1111. doi:10.1080/10717544.2017.135986128776443
   PubMed Web of Science ®Google Scholar
• Chowhan A, Giri TK. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route. Int J Biol Macromol. 2020;150:559–572. doi:10.1016/j.ijbiomac.2020.02.09732057864
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377–1397. doi:10.3390/polym303137722577513
   PubMed Web of Science ®Google Scholar
• Xu Y, Kim CS, Saylor DM, Koo D. Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories. J Biomed Mater Res B Appl Biomater. 2017;105(6):1692–1716. doi:10.1002/jbm.b.3364827098357
   PubMed Web of Science ®Google Scholar
• Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev. 2005;57(3):391–410. doi:10.1016/j.addr.2004.09.00315560948
   PubMed Web of Science ®Google Scholar
• Hafner AM, Corthesy B, Textor M, Merkle HP. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation. Int J Pharm. 2016;514(1):176–188. doi:10.1016/j.ijpharm.2016.07.04227863662
   PubMedGoogle Scholar
• Huh MS, Lee SY, Park S, et al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J Control Release. 2010;144(2):134–143. doi:10.1016/j.jconrel.2010.02.02320184928
   PubMed Web of Science ®Google Scholar
• Wusiman A, He J, Zhu T, et al. Macrophage immunomodulatory activity of the cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharide. Int J Biol Macromol. 2019;134:730–739. doi:10.1016/j.ijbiomac.2019.05.03831071396
   PubMed Web of Science ®Google Scholar
• Lu B, Lv X, Le Y. Chitosan-Modified PLGA nanoparticles for control-released drug delivery. Polymers. 2019;11:2. doi:10.3390/polym11020304
   Web of Science ®Google Scholar
• Bivas-Benita M, Lin MY, Bal SM, et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine. 2009;27(30):4010–4017. doi:10.1016/j.vaccine.2009.04.03319389445
   PubMed Web of Science ®Google Scholar
• Rose N, Opriessnig T, Grasland B, Jestin A. Epidemiology and transmission of porcine circovirus type 2 (PCV2). Virus Res. 2012;164(12):78–89. doi:10.1016/j.virusres.2011.12.00222178804
   PubMedGoogle Scholar
• Guo X, Zheng Q, Jiang X, et al. The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine. Vet Microbiol. 2019;228:69–76. doi:10.1016/j.vetmic.2018.11.01530593382
   PubMed Web of Science ®Google Scholar
• Zhang G, Jia P, Cheng G, et al. Enhanced immune response to inactivated porcine circovirus type 2 (PCV2) vaccine by conjugation of chitosan oligosaccharides. Carbohydr Polym. 2017;166:64–72. doi:10.1016/j.carbpol.2017.02.05828385249
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Quinn MT. Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol. 2006;6(3):317–333. doi:10.1016/j.intimp.2005.10.00516428067
   PubMed Web of Science ®Google Scholar
• Yu Q, Nie SP, Wang JQ, Yin PF, Li WJ, Xie MY. Polysaccharide from Ganoderma atrum induces tumor necrosis factor-alpha secretion via phosphoinositide 3-kinase/Akt, mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways in RAW264.7 cells. Int Immunopharmacol. 2012;14(4):362–368. doi:10.1016/j.intimp.2012.09.00523010818
   PubMed Web of Science ®Google Scholar
• Mulens-Arias V, Rojas JM, Perez-Yague S, Morales MP, Barber DF. Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials. 2015;52:494–506. doi:10.1016/j.biomaterials.2015.02.06825818455
   PubMed Web of Science ®Google Scholar
• Cruz LJ, Tacken PJ, Fokkink R, et al. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release. 2010;144(2):118–126. doi:10.1016/j.jconrel.2010.02.01320156497
   PubMed Web of Science ®Google Scholar
• Roopngam P. Poly (Lactic-Co-Glycolic) Acid (PLGA) adjuvant for immunotherapy. Immunol Disord Immunother. 2017;2:113. doi:10.35248/2593-8509.17.2.113
   Google Scholar
• Sahiner N, Sagbas S, Sahiner M, Ayyala RS. Polyethyleneimine modified poly(Hyaluronic acid) particles with controllable antimicrobial and anticancer effects. Carbohydr Polym. 2017;159:29–38. doi:10.1016/j.carbpol.2016.12.02428038751
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Y, Wang L, et al. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg. Mol Pharm. 2014;11(6):1772–1784. doi:10.1021/mp400597z24738485
   PubMedGoogle Scholar
• Luo L, Zheng S, Huang Y, et al. Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity. Int J Pharm. 2016;511(1):140–150. doi:10.1016/j.ijpharm.2016.06.13027374200
   PubMed Web of Science ®Google Scholar
• Bo R, Ma X, Feng Y, et al. Optimization on conditions of Lycium barbarum polysaccharides liposome by RSM and its effects on the peritoneal macrophages function. Carbohydr Polym. 2015;117:215–222. doi:10.1016/j.carbpol.2014.09.06025498628
   PubMed Web of Science ®Google Scholar
• Xu S, Wusiman A, Liu Z, et al. pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity. Int J Biol Macromol. 2019;125:865–875. doi:10.1016/j.ijbiomac.2018.12.15630576729
   PubMed Web of Science ®Google Scholar
• Qian Y, Liang X, Yang J, et al. Hyaluronan reduces cationic liposome-induced toxicity and enhances the antitumor effect of targeted gene delivery in mice. ACS Appl Mater Interfaces. 2018;10(38):32006–32016. doi:10.1021/acsami.8b1239330156827
   PubMed Web of Science ®Google Scholar
• Lu Y, Yang Y, Gu Z, et al. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy. Biomaterials. 2018;175:82–92. doi:10.1016/j.biomaterials.2018.05.02529803106
   PubMed Web of Science ®Google Scholar
• Godbey WT, Wu KK, Release A. Poly(ethylenimine) and its role in gene delivery. J Control Release. 1999;60(23):149–160. doi:10.1016/s0168-3659(99)00090-510425321
   PubMedGoogle Scholar
• Jeanbart L, Ballester M, de Titta A, et al. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res. 2014;2(5):436–447. doi:10.1158/2326-6066.Cir-14-0019-t24795356
   PubMed Web of Science ®Google Scholar
• Ebrahimian M, Hashemi M, Maleki M, et al. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice. Int J Pharm. 2016;515(12):708–720. doi:10.1016/j.ijpharm.2016.10.06527989827
   PubMedGoogle Scholar
• Akagi T, Baba M, Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Adv Adv Polymer Sci. 2012. doi:10.1007/12_2011_150
   Google Scholar
• Silva AL, Soema PC, Slutter B, Ossendorp F, Jiskoot W. PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity. Hum Vaccin Immunother. 2016;12(4):1056–1069. doi:10.1080/21645515.2015.111771426752261
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang L, Liu Y, et al. Immune responses to vaccines involving a combined antigen–nanoparticle mixture and nanoparticle-encapsulated antigen formulation. Biomaterials. 2014;35(23):6086–6097. doi:10.1016/j.biomaterials.2014.04.02224780166
   PubMed Web of Science ®Google Scholar
• Skwarczynski M, Toth I. Recent advances in peptide-based subunit nanovaccines. Nanomedicine. 2014;9(17):2657–2669. doi:10.2217/nnm.14.18725529569
   PubMed Web of Science ®Google Scholar
• Seok H, Noh JY, Lee DY, Kim SJ, Song CS, Kim YC. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles. J Control Release. 2017;265:66–74. doi:10.1016/j.jconrel.2017.04.02728434892
   PubMed Web of Science ®Google Scholar
• Zupancic E, Curato C, Paisana M, et al. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming. J Control Release. 2017;258:182–195. doi:10.1016/j.jconrel.2017.05.01428511928
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Z, Zhou L, Long T, Zhou X, Bao Y. Immunomodulatory effect of APS and PSP is mediated by Ca2(+)-cAMP and TLR4/NF-kappaB signaling pathway in macrophage. Int J Biol Macromol. 2017;94(PtA):283–289. doi:10.1016/j.ijbiomac.2016.10.01827732877
   PubMedGoogle Scholar
• Lu -X-X, Jiang Y-F, Li H, et al. Polymyxin B as an inhibitor of lipopolysaccharides contamination of herb crude polysaccharides in mononuclear cells. Chin J Nat Med. 2017;15(7):487–494. doi:10.1016/s1875-5364(17)30074-228807222
   PubMed Web of Science ®Google Scholar
• Inaba K, Inaba M. Antigen recognition and presentation by dendritic cells. Int J Hematol. 2005;81(3):181–187. doi:10.1532/IJH97.0420015814328
   PubMed Web of Science ®Google Scholar
• Kim SY, Noh YW, Kang TH, et al. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Biomaterials. 2017;130:56–66. doi:10.1016/j.biomaterials.2017.03.03428364631
   PubMed Web of Science ®Google Scholar
• Oreskovic Z, Kudlackova H, Krejci J, Nechvatalova K, Faldyna M. Oil-based adjuvants delivered intradermally induce high primary IgG2 immune response in swine. Res Vet Sci. 2017;114:41–43. doi:10.1016/j.rvsc.2017.03.00728319826
   PubMed Web of Science ®Google Scholar
• Petrovsky N. Comparative safety of vaccine adjuvants: a summary of current evidence and future needs. Drug Saf. 2015;38(11):1059–1074. doi:10.1007/s40264-015-0350-426446142
   PubMed Web of Science ®Google Scholar
• Singh D, Somani VK, Aggarwal S, Bhatnagar R. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants. Mol Immunol. 2015;68(2Pt A):272–279. doi:10.1016/j.molimm.2015.09.01126442664
   PubMedGoogle Scholar
• Hu Y, He K, Wang X. Role of Chinese herbal medicinal ingredients in secretion of cytokines by PCV2-induced endothelial cells. J Immunotoxicol. 2016;13(2):141–147. doi:10.3109/1547691X.2015.101762425721049
   PubMed Web of Science ®Google Scholar
• Wusiman A, Xu S, Ni H, et al. Immunomodulatory effects of Alhagi honey polysaccharides encapsulated into PLGA nanoparticles. Carbohydr Polym. 2019;211:217–226. doi:10.1016/j.carbpol.2019.01.10230824082
   PubMed Web of Science ®Google Scholar
• Malik A, Gupta M, Mani R, Bhatnagar R. Single-dose Ag85B-ESAT6-loaded poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis. Int J Nanomedicine. 2019;14:3129–3143. doi:10.2147/IJN.S17239131118627
   PubMed Web of Science ®Google Scholar
• Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS One. 2013;8(4):e61885. doi:10.1371/journal.pone.006188523637922
   PubMed Web of Science ®Google Scholar